PS-147 - ARO-AAT, a subcutaneous RNAi-based therapeutic for alpha-1 antitrypsin-related liver disease, demonstrates liver exposure-response and efficacy in preclinical studies
| Autor: | Wooddell, C., Blomenkamp, K., Chen, H., Griffin, J., Zhu, R., Chu, Q., Hamilton, H., Hegge, J., Christianson, D., Li, Z., Teckman, J., Given, B. |
|---|---|
| Zdroj: | In Journal of Hepatology April 2018 68 Supplement 1:S82-S82 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect